Tonix Pharmaceuticals Announces New Data Involving TNX-1500 in Heart Xenotransplantation in Animal Models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals has announced new data involving TNX-1500 in heart xenotransplantation in animal models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress.
October 30, 2023 | 11:18 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tonix Pharmaceuticals' announcement of new data involving TNX-1500 could potentially impact the company's stock in the short term.
The announcement of new data involving TNX-1500, a product of Tonix Pharmaceuticals, could potentially influence the company's stock. Investors and market watchers often react to such news, which could lead to increased trading activity and potential price movements.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100